Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07560709 | Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma | no longer available | — | — | University of FloridaOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT03874455 | Tazemetostat Expanded Access Program for Adults With Solid Tumors | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT04225429 | Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT03493165 | Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020) | no longer available | — | — | The University of Texas Health Science Center at San AntonioOTHER | 0 | May 28, 2025 | clinicaltrials |
| NCT02822495 | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies | no longer available | — | — | Atara BiotherapeuticsINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
| NCT03029481 | Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma | no longer available | — | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Mar 28, 2019 | clinicaltrials |
| NCT00210665 | A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment | no longer available | — | — | Janssen Research & Development, LLCINDUSTRY | 3 | Oct 10, 2017 | clinicaltrials |
| NCT02712567 | SARC021C: A Continuation Study of TH-CR-406/SARC021 | no longer available | — | — | Sarcoma Alliance for Research through CollaborationOTHER | 0 | Oct 13, 2016 | clinicaltrials |
| NCT02570412 | Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy | no longer available | — | — | CytRxINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01427582 | YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access | no longer available | — | — | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 1, 2011 | clinicaltrials |
Data updated 4 days agoSource updated Sep 23, 2026source: clinicaltrials